VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VRDN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VRDNViridian Therapeutics, Inc.
$18.80$1.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVRDNQuarterly Financials

Viridian Therapeutics, Inc. (VRDN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Viridian Therapeutics, Inc. (VRDN) quarterly income statement — complete revenue, gross profit & net income history

VRDN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue141K132K70.57M75K72K72K86K72K72K72K72K72K98K105K1.2M256K216K214K208K1.09M
Revenue Growth %95.83%83.33%81958.14%4.17%0%0%19.44%0%-26.53%-31.43%-93.97%-71.88%-54.63%-50.93%474.52%-76.51%-85.11%296.3%-548.81%
Cost of Goods Sold121K320K0000000000039.32M22.12M21.71M17.75M22.39M8.12M12.56M
COGS % of Revenue85.82%242.42%-----------37444.76%1850.96%8481.25%8215.74%10464.49%3904.33%1152.75%
Gross Profit20K-188K70.57M75K72K72K86K72K72K72K72K72K98K-39.21M-20.92M-21.46M-17.53M-22.18M-7.91M-11.47M
Gross Margin %14.18%-142.42%100%100%100%100%100%100%100%100%100%100%100%-37344.76%-1750.96%-8381.25%-8115.74%-10364.49%-3804.33%-1052.75%
Gross Profit Growth %-72.22%-361.11%81958.14%4.17%0%0%19.44%0%-26.53%100.18%100.34%100.34%100.56%-76.79%-164.43%-86.98%-41.89%-45.92%--6930.36%
Operating Expenses116.31M122.56M110.58M106.84M93.94M87.54M83.57M72.26M55.97M71.55M51.3M59.35M72.57M9.85M8.86M8.11M8.36M6.9M6.22M6.52M
OpEx % of Revenue82489.36%92849.24%156.7%142456%130469.44%121588.89%97169.77%100359.72%77734.72%99375%71244.44%82426.39%74052.04%9384.76%741.51%3167.19%3869.91%3224.77%2990.87%598.44%
Selling, General & Admin38.68M33.67M24.32M20.22M17.1M15.58M14.41M16.07M15.03M32.99M20.91M19.26M21.83M9.85M8.86M8.11M8.36M6.9M6.22M6.52M
SG&A % of Revenue27431.91%25510.61%34.47%26954.67%23754.17%21644.44%16753.49%22313.89%20868.06%45823.61%29043.06%26755.56%22276.53%9384.76%741.51%3167.19%3869.91%3224.77%2990.87%598.44%
Research & Development77.63M89.21M86.26M86.63M76.83M71.96M69.16M56.19M40.94M38.56M30.39M40.08M50.74M39.32M22.12M21.71M17.75M22.39M8.12M12.56M
R&D % of Revenue55057.45%67581.06%122.23%115501.33%106715.28%99944.44%80416.28%78045.83%56866.67%53551.39%42201.39%55670.83%51775.51%37444.76%1850.96%8481.25%8215.74%10464.49%3904.33%1152.75%
Other Operating Expenses0-320K00000000000-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-116.17M-122.75M-40.01M-106.77M-93.87M-87.47M-83.48M-72.19M-55.9M-71.48M-51.22M-59.27M-72.47M-49.07M-29.79M-29.56M-25.89M-29.08M-14.13M-18M
Operating Margin %-82389.36%-92991.67%-56.7%-142356%-130369.44%-121488.89%-97069.77%-100259.72%-77634.72%-99275%-71144.44%-82326.39%-73952.04%-46729.52%-2492.47%-11548.44%-11985.65%-13589.25%-6795.19%-1651.19%
Operating Income Growth %-23.76%-40.33%52.07%-47.9%-67.93%-22.38%-62.97%-21.78%22.87%-45.68%-71.98%-100.5%-179.94%-68.72%-110.73%-64.26%-39.83%67.9%-161.26%-182.37%
EBITDA-116.05M-123.09M-39.9M-106.65M-93.75M-87.35M-83.35M-72.05M-55.75M-71.33M-51.09M-59.14M-72.37M-48.97M-29.72M-29.51M-25.85M-29.05M-14.1M-17.97M
EBITDA Margin %-82303.55%-93249.24%-56.54%-142205.33%-130206.94%-121318.06%-96918.6%-100062.5%-77433.33%-99066.67%-70956.94%-82143.06%-73844.9%-46638.1%-2487.28%-11526.17%-11967.13%-13574.3%-6780.77%-1648.9%
EBITDA Growth %-23.79%-40.92%52.13%-48.04%-68.15%-22.46%-63.15%-21.81%22.96%-45.66%-71.88%-100.44%-179.96%-68.58%-110.74%-64.17%-39.86%67.92%-163.48%-184.83%
D&A (Non-Cash Add-back)121K-340K110K113K117K123K130K142K145K150K135K132K105K96K62K57K40K32K30K25K
EBIT-116.17M-113.75M-34.04M-100.22M-86.33M-78.87M-75.69M-64.4M-47.95M-65.94M-51.22M-54.9M-67.99M-49.07M-29.79M-29.56M-25.89M-29.08M-14.13M-18M
Net Interest Income4.41M1.18M4.96M6.03M6.95M7.75M6.79M7.19M7.36M4.62M3.56M4.21M4.32M3.28M880K73K196K135K91K34K
Interest Income7.87M7.79M5.52M6.55M7.54M8.61M7.79M7.79M7.94M5.53M4.16M4.38M4.49M3.45M1.04M227K196K138K91K34K
Interest Expense3.46M6.61M560K514K586K858K1M597K587K916K600K166K165K168K164K154K03K00
Other Income/Expense11.27M2.39M5.41M6.03M6.95M7.75M6.79M7.19M7.36M4.62M3.56M4.21M4.32M3.28M880K73K196K135K91K34K
Pretax Income-104.9M-120.36M-34.6M-100.73M-86.91M-79.72M-76.69M-64.99M-48.54M-66.86M-47.66M-55.06M-68.15M-45.78M-28.91M-29.49M-25.69M-28.95M-14.04M-17.96M
Pretax Margin %-74397.87%-91178.03%-49.03%-134313.33%-120711.11%-110729.17%-89173.26%-90268.06%-67419.44%-92861.11%-66194.44%-76476.39%-69541.84%-43604.76%-2418.83%-11519.92%-11894.91%-13526.17%-6751.44%-1648.07%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-104.9M-120.36M-34.6M-100.73M-86.91M-79.72M-76.69M-64.99M-48.54M-66.86M-47.66M-55.06M-68.15M-45.78M-28.91M-29.49M-25.69M-28.95M-14.04M-17.96M
Net Margin %-74397.87%-91178.03%-49.03%-134313.33%-120711.11%-110729.17%-89173.26%-90268.06%-67419.44%-92861.11%-66194.44%-76476.39%-69541.84%-43604.76%-2418.83%-11519.92%-11894.91%-13526.17%-6751.44%-1648.07%
Net Income Growth %-20.7%-50.96%54.88%-54.99%-79.05%-19.24%-60.91%-18.03%28.77%-46.03%-64.89%-86.71%-165.25%-58.17%-105.83%-64.17%-39.18%68.1%-155.61%-179.16%
Net Income (Continuing)-104.9M-120.36M-34.6M-100.73M-86.91M-79.72M-76.69M-64.99M-48.54M-66.86M-47.66M-55.06M-68.15M-45.78M-28.91M-29.49M-25.69M-28.95M-14.04M-17.96M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.03-1.11-0.34-1.00-0.87-0.81-1.15-1.02-0.79-1.35-1.09-1.27-1.61-1.05-0.83-1.06-0.98-2.59-1.26-2.22
EPS Growth %-18.39%-37.04%70.43%1.96%-10.13%40%-5.5%19.68%50.93%-28.57%-31.33%-19.81%-64.29%59.46%34.13%52.25%66.32%88.77%14.86%-21.98%
EPS (Basic)-1.03-1.11-0.34-1.00-0.87-0.81-1.15-1.02-0.79-1.35-1.09-1.27-1.61-1.05-0.83-1.06-0.98-2.59-1.26-2.22
Diluted Shares Outstanding102.21M84.8M81.78M81.59M81.34M80.05M66.42M63.85M61.1M49.68M43.65M43.25M42.24M40.54M33.74M27.76M26.13M11.18M11.18M8.11M
Basic Shares Outstanding102.21M84.8M81.78M81.59M81.34M80.05M66.42M63.85M61.1M49.68M43.65M43.25M42.24M40.54M33.74M27.76M26.13M11.18M11.18M8.11M
Dividend Payout Ratio--------------------